GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $13,000 | -99.8% | 60 | -99.9% | 0.00% | -100.0% |
| Q4 2020 | $6,183,000 | +16.7% | 53,573 | -1.6% | 0.06% | -5.8% |
| Q3 2020 | $5,298,000 | -22.0% | 54,418 | -1.7% | 0.07% | -27.4% |
| Q2 2020 | $6,791,000 | +37.1% | 55,336 | -2.2% | 0.10% | +9.2% |
| Q1 2020 | $4,955,000 | -15.7% | 56,583 | +0.7% | 0.09% | +11.5% |
| Q4 2019 | $5,876,000 | +35.3% | 56,193 | +48.9% | 0.08% | +27.9% |
| Q3 2019 | $4,342,000 | -4.1% | 37,745 | +43.7% | 0.06% | -11.6% |
| Q2 2019 | $4,529,000 | +1.2% | 26,271 | -1.0% | 0.07% | -4.2% |
| Q1 2019 | $4,474,000 | +50.1% | 26,540 | -13.3% | 0.07% | +22.0% |
| Q4 2018 | $2,980,000 | – | 30,596 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |